Eotaxin-2 (ccl24) inhibitors in inflammatory, autoimmune,...

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 16/24 (2006.01) A61K 39/00 (2006.01) C07K 14/52 (2006.01)

Patent

CA 2750952

The present invention is based on the finding that inhibition of eotaxin-2 by polyclonal or monoclonal antibodies, has a significant protective effect in animal models of inflammatory diseases such as rheumatoid arthritis, experimental autoimmune encephalomyelitis (EAE), colitis, diabetes, and atherosclerosis. The invention thus provides pharmaceutical compositions comprising specific anti-eotaxin 2 antibodies for use alone or in combination with other therapeutic agents in the treatment of inflammatory, autoimmune and cardiovascular diseases. The invention also provides specific anti-eotaxin-2 monoclonal antibodies, and methods of treatment utilizing the antibodies of the invention.

La présente invention est basée sur la découverte que l'inhibition de l'éotaxine-2 par des anticorps polyclonaux ou monoclonaux a un effet protecteur important dans des modèles animaux contre des maladies inflammatoires telles que la polyarthrite rhumatoïde, l'encéphalomyélite auto-immune expérimentale (EAE), la colite, le diabète et l'athérosclérose. L'invention porte donc sur des compositions pharmaceutiques comprenant des anticorps spécifiques dirigés contre l'éotaxine-2, destinés à être utilisés seuls ou en association avec d'autres agents thérapeutiques dans le traitement de maladies inflammatoires, auto-immunes et cardiovasculaires. L'invention porte également sur des anticorps monoclonaux spécifiques dirigés contre l'éotaxine-2 et sur des procédés de traitement utilisant les anticorps de l'invention.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Eotaxin-2 (ccl24) inhibitors in inflammatory, autoimmune,... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Eotaxin-2 (ccl24) inhibitors in inflammatory, autoimmune,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Eotaxin-2 (ccl24) inhibitors in inflammatory, autoimmune,... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1585569

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.